Axon Enterprise (AXON) Earnings Date & Reports

Axon Enterprise delivered robust Q1 2026 results, reporting total revenue of $807 million, a 34% increase from $604 million in Q1 2025 and surpassing analyst consensus of around $780 million. Software & Services revenue hit $355 million (35% YoY growth), fueled by AI products like Draft One and Axon Assistant growing over 700% YoY, with ARR at $1.5 billion (up 35%) and net revenue retention of 125%. Connected Devices generated $453 million (33% YoY), with TASER at $233 million (+19%), Personal Sensors +23%, and Platform Solutions $111 million (+95%), led by counter-drone up over 300%.

GAAP net income rose to $169 million ($2.05 diluted EPS, 21.0% margin) from $88 million ($1.08 EPS). Non-GAAP net income was $133 million ($1.61 diluted EPS), up from $120 million ($1.47), slightly missing the $1.66 consensus. Adjusted EBITDA grew 30% to $202 million (25.0% margin). Gross margin dipped to 59.1% due to tariffs and Dedrone mix, but adjusted gross margin was 61.6%. Operating cash flow was an outflow of $32 million amid investments.

Axon raised 2026 guidance: revenue growth to 30-32%, adjusted EBITDA margin 25.5%, operating cash flow over $600 million, free cash flow ~$450 million.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization (market cap), technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your analysis.

Market Reaction and Investor Sentiment

Post-earnings, AXON shares rose about 1.14% in after-hours trading on May 6, 2026, reflecting approval of the revenue beat, AI momentum, and raised guidance despite the slight non-GAAP EPS miss. Investors focused on top-line strength and future contracted bookings of $14.3 billion, signaling robust demand. Sentiment remains positive, with historical post-earnings moves averaging +14.8% over recent quarters, though muted here amid high expectations.

Forward Outlook and Key Factors to Monitor

Axon's raised 2026 revenue guidance of 30-32% growth highlights confidence in sustained demand for TASER, body cameras, and software platforms. Key drivers include the AI Era Plan, with expansions like Axon Vision (field trials mid-2026) and smartwatch integrations later in the year.

Counter-drone solutions, growing over 300% YoY, benefit from U.S. events like World Cup 2026 and Safer Skies Act grants ($250 million federal funding). Future bookings of $14.3 billion provide visibility, with 20-25% fulfillment expected in the next 12 months.

Investors should track gross margin recovery amid tariffs and Dedrone integration, stock-based compensation ($590-620 million), and CapEx ($160-190 million). Free cash flow guidance of ~$450 million supports investments without new headquarters costs. Broader factors include international expansion (20% of revenue) and AI adoption in justice workflows.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations